Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

servier laboratories nz ltd - pegaspargase 3750 u (4050u including overage) - powder for injection - 3750 u/5ml - active: pegaspargase 3750 u (4050u including overage) excipient: dibasic sodium phosphate hydrochloric acid monobasic sodium phosphate sodium chloride sodium hydroxide sucrose - oncaspar is indicated as a component of antineoplastic combination therapy in patients with acute lymphoblastic leukaemia (all).

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

servier laboratories nz ltd - perindopril erbumine 8mg - tablet - 8 mg - active: perindopril erbumine 8mg excipient: colloidal silicon dioxide chlorophyllin aluminium lake (e14ii) lactose monohydrate magnesium stearate microcrystalline cellulose - coversyl is indicated for: · the treatment of hypertension.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

servier laboratories australia pty ltd - ivabradine hydrochloride -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

servier laboratories australia pty ltd - ivabradine hydrochloride -

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

servier laboratories nz ltd - strontium ranelate 2632mg - granules for oral suspension - 2 g - active: strontium ranelate 2632mg excipient: aspartame maltodextrin mannitol - treatment of severe (established) osteoporosis in postmenopausal women at high risk of fracture to reduce the risk of fracture.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - agomelatine, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; stearic acid; colloidal anhydrous silica; sodium starch glycollate type a; maize starch; lactose monohydrate; propylene glycol; butan-1-ol; ethanol; isopropyl alcohol; shellac; strong ammonia solution; indigo carmine aluminium lake; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; glycerol - treatment in adults of: - of major depression (mdd) including prevention of relapse - generalised anxiety disorder (gad)

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; hypromellose; pregelatinised maize starch; carnauba wax; magnesium stearate; mannitol; iron oxide yellow; indigo carmine; titanium dioxide; macrogol 6000 - latuda is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: hypromellose; carnauba wax; magnesium stearate; mannitol; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; macrogol 6000 - latuda is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 13.87 mg; perindopril arginine, quantity: 10 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate; magnesium stearate - apx-perindopril arginine/ amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 6.935 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - apx-perindopril arginine/ amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.